Nike still looks like a strong brand with a loyal customer base, but growth has cooled and the business may need time to find its next stride. The key question is whether today’s price already assumes a smooth rebound, or whether patient buyers might get a better entry if the turnaround takes longer.Read more

Oracle looks like it’s priced for a lot of optimism, even though some signs point to slower returns and higher uncertainty than many investors expect. The story breaks down why different ways of thinking about value lead to very different answers—and what would need to change to make it a clearer buy.Read more

️ Business Overview Key Metrics Total: -2.5/17 +1 ✅ Projected Operating Margin: 12% +0 ⚠️ Projected 5-Year Revenue CAGR: 8% +0 ⚠️ Last 5-Year ROIC: 9.83% +0 ⚠️ Estimated Cost of Capital: 9.83% (around ROIC) -1 ❌ Last 5-Year Shares Outstanding CAGR: +0.50% +1 ✅ Projected 5-Year EPS CAGR: 12.36% +1 ✅ Projected 5-Year Dividend CAGR: 11.63% -1.5 ❌ Estimated Debt Rating: B1 -2 ❌❌ Morningstar Moat: None -1 ❌ Morningstar Uncertainty: High During the 2030 projections, the Mota-Engil management projected the following for the future of the company: 2026 Revenue Growth : to accelerate to 10-15% Operating Margin to be sustained around 11-12% Net Margin to be maintained around 2.5-3% EPS to grow from 0.43 euros to 0.47-0.60 2030 Revenue Growth 9.000 million by 2030, representing a 10% CAGR Operating Margin to expand into >= 13% Net Margin to expand into >=4% EPS to grow from 0.43 euros to 0.55-1.17 (this are my expectations, given my lower to higher assumptions, presented later on during this valuation). To be honest this confident and overall good projections by the management took me by surprise and I reavaluated my position on the company.Read more

Business Overview Key Metrics Total: 9/17 +2 ✅ Projected Operating Margin: 20.22% +0 ⚠️ Projected 5-Year Revenue CAGR: 4.92% +2 ✅✅ Last 5-Year ROIC: 82.83% +1 ✅ Estimated Cost of Capital: 8.14% (less than ROIC) +1 ✅ Last 5-Year Shares Outstanding CAGR: -1.79% -1 ❌ Projected 5-Year EPS CAGR: 9.87% (given the easiness of "manipulation" of EPS growth below 10% represents a slight negative) +1 ✅ Projected 5-Year Dividend CAGR: 10.47% +1 ✅ Estimated Debt Rating: A3 +2 ✅✅ Morningstar Moat: Wide +0 ⚠️ Morningstar Uncertainty: Medium Domino's Pizza is a great brand, enjoying a wide moat that results in an operating margin of around ~ 20%. Given the maturity of the business, its revenue growth is below 10% but still modestly above the economy growth rate.Read more

Business Overview Key Metrics Total: 1/17 +1 ✅ Projected Operating Margin: 10.00% +0 ⚠️ Projected 5-Year Revenue CAGR: 8.60% +0 ⚠️ Last 5-Year ROIC: 5.12% -2 ❌❌ Estimated Cost of Capital: 7.46% (greater than ROIC) +1 ✅ Last 5-Year Shares Outstanding CAGR: -2.84% +2 ✅✅ Projected 5-Year EPS CAGR: 23.74% +0 ⚠️ Projected 5-Year Dividend CAGR: 7.72% +1 ✅ Estimated Debt Rating: A3 -1 ❌ Morningstar Moat: Narrow -1 ❌ Morningstar Uncertainty: High CTT has spent decades building an unrivalled logistics operation in Portugal — density, efficiency, and customer trust that took years to develop. It is now exporting that model into Spain, a larger and underpenetrated market.Read more

Business Overview Key Metrics Total: 9.5/17 +2✅✅ Projected Operating Margin: 65.63% +0 ⚠️ Projected 5-Year Revenue CAGR: 9.43% +2 ✅✅ Last 5-Year ROIC: 39.70% +1 ✅ Estimated Cost of Capital: 6.26% (lower than ROIC) -1 ❌ Last 5-Year Shares Outstanding CAGR: +0.15% +1 ✅ Projected 5-Year EPS CAGR: 12.38% +1 ✅ Projected 5-Year Dividend CAGR: 12.50% +1.5 ✅ Estimated Debt Rating: Aa3 +2 ✅✅ Morningstar Moat: Wide +0 ⚠️ Morningstar Uncertainty: Medium Business Valuation To calculate the intrinsic value of the company I'll use multiple methods: Discounted Cash Flows (DCF) - Intrinsic value is estimated by projecting its free cash flows over the next 10 years and discounting them to present value using the estimated cost of capital ; EPS Growth - the fair value is estimated by projected the Earnings Per Share CAGR for the next 5 Years and then, given its current and historic values of PE, come up with a PE for the 5th Year. This will give us its price 5 Years from now using the formula: Price = EPS x PE that we then discount using the estimated cost of capital; Historical P/E - we assume mean reversion to the historical P/E values; Historical EV/EBITDA - we assume mean reversion to the historical EV/EBITDA values.Read more

Business Overview Key Metrics Total: 4/17 +1 ✅ Projected Operating Margin: 18.84% +0 ⚠️ Projected 5-Year Revenue CAGR: 4.73% +2 ✅✅ Last 5-Year ROIC: 45.98% +1 ✅ Estimated Cost of Capital: 7.18% (lower than ROIC) +1 ✅ Last 5-Year Shares Outstanding CAGR: -2.51% -1 ❌ Projected 5-Year EPS CAGR: 6.92% (lower than 10%) +0 ⚠️ Projected 5-Year Dividend CAGR: N/A +2 ✅✅ Estimated Debt Rating: Aaa -1 ❌ Morningstar Moat: Narrow -1 ❌ Morningstar Uncertainty: High Business Valuation To calculate the intrinsic value of the company I'll use multiple methods: Discounted Cash Flows (DCF) - Intrinsic value is estimated by projecting its free cash flows over the next 10 years and discounting them to present value using the estimated cost of capital ; EPS Growth - the fair value is estimated by projected the Earnings Per Share CAGR for the next 5 Years and then, given its current and historic values of PE, come up with a PE for the 5th Year. This will give us its price 5 Years from now using the formula: Price = EPS x PE that we then discount using the estimated cost of capital; Historical EV/EBITDA - we assume mean reversion to the historical EV/EBITDA values; Historical P/E - we assume mean reversion to the historical P/E values; Historical P/S - we assume mean reversion to the historical P/S values.Read more

🩺 Business Overview Key Metrics Total: -3/17 +1 ✅ Projected Operating Margin: 12.62% +1 ✅ Projected 5-Year Revenue CAGR: 12.64% -2 ❌❌ Last 5-Year ROIC: -18.95% -2 ❌❌ Estimated Cost of Capital: 7.70% (greater than ROIC) -1 ❌ Last 5-Year Shares Outstanding CAGR: +8.43% +2 ✅✅ Projected 5-Year EPS CAGR: 27.08% +0 ⚠️ Projected 5-Year Dividend CAGR: N/A +2 ✅✅ Estimated Debt Rating: Aaa -2 ❌❌ Morningstar Moat: None -2 ❌❌ Morningstar Uncertainty: Very High Hims & Hers Health is a high growth company, being currently on a rapid expansion of its business. This has some advantages like the projected stellar growth of both revenue and EPS but it will also normally represent the dillution of shares to support it and the negative ROIC (lower than the cost of capital) that it should be regularized during the next couple of years.Read more

Business Overview Key Metrics Total: 1/17 +2 ✅ Projected Operating Margin: 45.47% +0 ⚠️ Projected 5-Year Revenue CAGR: 4.70% +0 ⚠️ Last 5-Year ROIC: 2.52% -2 ❌❌ Estimated Cost of Capital: 7.18% (higher than ROIC) -1 ❌ Last 5-Year Shares Outstanding CAGR: 12.11% +1 ✅ Projected 5-Year EPS CAGR: 11.68% +0 ⚠️ Projected 5-Year Dividend CAGR: 3.46% +1 ✅ Moody's Rating: A3 -2 ❌❌ Morningstar Moat: None +2 ✅✅ Morningstar Uncertainty: Low Realty Income is a reliable dividend payer. It's true that its growing its dividend at a rate a little below or a the economy growth rate ~3%, but its low uncertainty makes this company a safe bet for every dividend investor.Read more